Clinical Commander

Back to dossier
cardio.cardiac-tamponade.aortic-dissection-related.v1PRODUCTION
cardio.cardiac-tamponade.aortic-dissection-related.v1

Cardiac tamponade — Type A aortic dissection-related (hemopericardium)

cardiologyacuteadult
Hard-required inputs
0 / 9
Care setting:

Encounter flow

9/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Type A dissection-related tamponade — DO NOT default to full pericardiocentesis; emergent cardiothoracic surgery is definitive; limited bridge drainage (≤50 mL) ONLY if hypotensive (ACC/AHA 2022; Hayashi Circ J 2012)

Inputs
1
Actions
0
Advance rule
Set
Advance when

dissection-context tamponade physiology suspected

Patient inputs (10)

Older patients have higher Type A mortality + worse surgical outcomes; bicuspid valve and connective tissue disorders shift age distribution younger (ACC/AHA 2022 PMID 36066317)

Goal HR <60 with esmolol BEFORE vasodilator added; reflex tachycardia from isolated vasodilator worsens dissection propagation (ACC/AHA 2022; Erbel ESC 2014)

Marfan, Loeys-Dietz, Ehlers-Danlos vascular type, bicuspid aortic valve, prior aortic surgery, hypertension history all modify pre-test probability + recurrence risk (ACC/AHA 2022)

Bedside TTE/TEE definitive for tamponade physiology + root dissection flap visualization; TEE preferred if hemodynamically unstable for transport (Class I; ACC/AHA 2022)

Gold-standard definitive imaging for dissection extent, branch-vessel involvement, pericardial blood quantification — must be obtained when patient stable for transport (Hagan IRAD JAMA 2000 PMID 10685714)

Baseline for contrast-related AKI risk + post-op AKI surveillance + dose-adjustment for any sedation/analgesia

Baseline + serial for hemorrhagic loss + transfusion threshold; massive transfusion likely intraoperatively

Coagulopathy reversal pre-OR + tracking massive transfusion balance

Hypotension is part of Beck triad AND signals tamponade physiology, malperfusion shock, or aortic rupture; goal SBP <120 with anti-impulse therapy once dissection confirmed (ACC/AHA 2022 Class I)

Highly sensitive (>97%) for acute aortic dissection if <500 ng/mL within 24h of symptom onset rules out with high NPV (ACC/AHA 2022 ADD-RS supplement)

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (5)

5 need judgement
  • informationallife_threateningmalperfusion_syndrome_with_organ_compromise
    Branch-vessel malperfusion (cerebral, coronary, mesenteric, renal, spinal, limb) accompanying Type A dissection-tamponade — multisystem organ ischemia (ACC/AHA 2022 PMID 36066317; Trimarchi IRAD)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningparaplegia_from_spinal_artery_compromise
    Lower extremity weakness/paralysis indicating Adamkiewicz artery (T8-L1) compromise during/after Type A repair — spinal cord ischemia (ACC/AHA 2022)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningorgan_system_progression_renal_or_mesenteric
    New AKI (Cr doubled) or mesenteric ischemia (lactate >4 + abdominal pain + leukocytosis) following Type A repair — branch-vessel malperfusion sequelae (Trimarchi IRAD)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningpre_operative_cardiac_arrest_with_pea_or_pulseless
    Pre-operative cardiac arrest in Type A dissection-tamponade with PEA or pulseless rhythm — mechanical obstruction physiology requires controlled bridge drainage as temporizing maneuver to OR (Hayashi Circ J 2012; ACC/AHA 2022)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseveredissection_extension_on_serial_imaging
    Dissection extension distally on serial CT (within 24-72h) — propagation despite anti-impulse therapy (ACC/AHA 2022; Erbel ESC 2014)
    Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

Run this disease's risk and dosing calculators inline.

RED_FLAGSrequiredDrives risk stratification
Loading…

Recommended regimen

Type A dissection tamponade — anti-impulse therapy first + LIMITED pericardiocentesis bridge ONLY + emergent OR (ACC/AHA 2022; Hayashi Circ J 2012)
axis: aortic_dissection_tamponade_anti_impulse_and_limited_bridge
Selected axis "Type A dissection tamponade — anti-impulse therapy first + LIMITED pericardiocentesis bridge ONLY + emergent OR (ACC/AHA 2022; Hayashi Circ J 2012)" by default fallback (first axis)
  • esmolol
    first line
    beta_blocker_short_acting_iv
    500 µg/kg IV bolus over 1 min then 50 µg/kg/min infusion titrate to HR <60 • IV • continuous infusion
    triggers: confirmed_or_suspected_type_a_dissection
    ACC/AHA 2022 Class I — short-acting BB first to reduce HR + dP/dt; titratability critical given hemodynamic lability. Achieve HR <60 BEFORE adding vasodilator (Erbel ESC 2014).
    rxcui 49737
  • labetalol
    first line
    mixed_alpha_beta_blocker
    10-20 mg IV bolus then 0.5-2 mg/min infusion titrate • IV • bolus + infusion
    triggers: esmolol_unavailable_or_chronic_bb_continuation
    ACC/AHA 2022 — alternative first-line; combined alpha/beta blockade for SBP + HR control simultaneously
    rxcui 6185
  • nicardipine
    add on
    dihydropyridine_ccb_iv
    5 mg/h IV titrate to SBP <120 (max 15 mg/h) • IV • continuous infusion
    triggers: sbp_gt_120_after_hr_lt_60_achieved_with_bb
    ACC/AHA 2022 Class I — ADD vasodilator ONLY after BB-induced HR control to prevent reflex tachycardia + dP/dt rise; isolated vasodilator AVOIDED
    rxcui 7396
  • norepinephrine
    rescue
    vasopressor
    0.05-0.1 µg/kg/min titrate to MAP ≥65 — CAUTIOUS, propagates dissection at higher doses • IV • continuous
    triggers: sbp_lt_85_with_tamponade_physiology_pre_or_bridge
    Bridge only — does not address tamponade obstruction OR dissection; titrate to LOWEST dose maintaining cerebral + coronary perfusion (Roy JAMA 2007; ACC/AHA 2022)
    rxcui 7512
  • acetaminophen
    first line
    analgesic_aniline
    1000 mg IV (max 4 g/24h) • IV • q6h scheduled
    triggers: acute_dissection_pain
    Pain reduction reduces sympathetic surge → reduces dP/dt + propagation risk (ACC/AHA 2022)
    rxcui 161
  • fentanyl
    add on
    opioid
    25-50 µg IV q5-10 min titrate • IV • as needed
    triggers: breakthrough_dissection_pain
    Reduces sympathetic surge + dP/dt; titratable + short half-life appropriate for surgical staging (ACC/AHA 2022)
    rxcui 4337
  • protamine
    rescue
    heparin_antagonist
    1 mg per 100 U residual heparin (max 50 mg single dose) • IV slow • pre-procedure if recent UFH
    triggers: recent_ufh_pre_or_or_bridge_drainage
    Reverse residual UFH from anticoagulation prior to OR or bridge drainage if active (ACC/AHA 2022)
    rxcui 8825
  • 4-factor prothrombin complex concentrate
    rescue
    pcc_4_factor
    25-50 U/kg based on INR • IV • single dose pre-OR
    triggers: warfarin_use_with_dissection_pre_op
    Emergent reversal pre-cardiac surgery if anticoagulated
    rxcui 1670383

outpatient playbook — drug actions (4)

  1. 1. maintenance BB + ARB
    rxcui 20352
    metoprolol succinate + losartan at target dose • PO • daily
    trigger: Post-Type-A repair lifelong
    ACC/AHA 2022 Class I — lifelong anti-impulse + BP control
  2. 2. anticoagulation per indication
    rxcui 11289
    warfarin or DOAC per indication • PO • per agent
    trigger: Ongoing indication
    AHA 2020 + ACC/AHA 2022
  3. 3. statin per ASCVD risk
    rxcui 83367
    atorvastatin 20-80 mg daily per LDL goal • PO • daily
    trigger: ASCVD risk + dissection cohort secondary prevention
    ACC/AHA 2018 cholesterol + 2022 aortic — comprehensive secondary prevention
  4. 4. colchicine if late post-pericardiotomy syndrome
    rxcui 2555
    0.5 mg BID + ibuprofen 600 mg TID × 1-3 mo • PO • BID + TID
    trigger: Symptomatic post-pericardiotomy syndrome
    Imazio CIRCS NEJM 2015 PMID 26315582

Auto-drafted A&P note

outpatient

Subjective

- Possible entry pathways: Sudden tearing chest/interscapular back pain + Beck triad (hypotension + JVD + muffled heart sounds) — Type A dissection with tamponade until proven otherwise (ACC/AHA 2022 PMID 36066317); STAT TTE: aortic root dissection flap + pericardial effusion + RV diastolic collapse → Type A dissection-related tamponade (Class I; ACC/AHA 2022; ESC 2014); CTA chest (definitive when stable enough): ascending aorta dissection flap + hemopericardium → emergent cardiothoracic surgery (Hagan IRAD JAMA 2000).

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Cardiac tamponade — Type A aortic dissection-related (hemopericardium)** (cardio.cardiac-tamponade.aortic-dissection-related.v1).
Phenotype framing: Confirm Type A (ascending aorta involvement) vs Type B (descending only — does not cause tamponade); rule out concomitant rupture into pleural space; assess branch-vessel involvement (Hagan IRAD JAMA 2000 PMID 10685714)
Scope: Type A dissection-related tamponade — DO NOT default to full pericardiocentesis; emergent cardiothoracic surgery is definitive; limited bridge drainage (≤50 mL) ONLY if hypotensive (ACC/AHA 2022; Hayashi Circ J 2012)

No severity triggers fired against current inputs.

Plan

Regimen axis: **Type A dissection tamponade — anti-impulse therapy first + LIMITED pericardiocentesis bridge ONLY + emergent OR (ACC/AHA 2022; Hayashi Circ J 2012)**.
1. esmolol 500 µg/kg IV bolus over 1 min then 50 µg/kg/min infusion titrate to HR <60 IV continuous infusion (beta_blocker_short_acting_iv, first line) — ACC/AHA 2022 Class I — short-acting BB first to reduce HR + dP/dt; titratability critical given hemodynamic lability. Achieve HR <60 BEFORE adding vasodilator (Erbel ESC 2014).
2. labetalol 10-20 mg IV bolus then 0.5-2 mg/min infusion titrate IV bolus + infusion (mixed_alpha_beta_blocker, first line) — ACC/AHA 2022 — alternative first-line; combined alpha/beta blockade for SBP + HR control simultaneously
3. nicardipine 5 mg/h IV titrate to SBP <120 (max 15 mg/h) IV continuous infusion (dihydropyridine_ccb_iv, add on) — ACC/AHA 2022 Class I — ADD vasodilator ONLY after BB-induced HR control to prevent reflex tachycardia + dP/dt rise; isolated vasodilator AVOIDED
4. norepinephrine 0.05-0.1 µg/kg/min titrate to MAP ≥65 — CAUTIOUS, propagates dissection at higher doses IV continuous (vasopressor, rescue) — Bridge only — does not address tamponade obstruction OR dissection; titrate to LOWEST dose maintaining cerebral + coronary perfusion (Roy JAMA 2007; ACC/AHA 2022)
5. acetaminophen 1000 mg IV (max 4 g/24h) IV q6h scheduled (analgesic_aniline, first line) — Pain reduction reduces sympathetic surge → reduces dP/dt + propagation risk (ACC/AHA 2022)
6. fentanyl 25-50 µg IV q5-10 min titrate IV as needed (opioid, add on) — Reduces sympathetic surge + dP/dt; titratable + short half-life appropriate for surgical staging (ACC/AHA 2022)
7. protamine 1 mg per 100 U residual heparin (max 50 mg single dose) IV slow pre-procedure if recent UFH (heparin_antagonist, rescue) — Reverse residual UFH from anticoagulation prior to OR or bridge drainage if active (ACC/AHA 2022)
8. 4-factor prothrombin complex concentrate 25-50 U/kg based on INR IV single dose pre-OR (pcc_4_factor, rescue) — Emergent reversal pre-cardiac surgery if anticoagulated

Setting playbook (outpatient) — Long-term surveillance for re-dissection, distal aortic progression, late graft complications, post-pericardiotomy late presentation, family screening completion (ACC/AHA 2022)
9. maintenance BB + ARB metoprolol succinate + losartan at target dose PO daily — Post-Type-A repair lifelong (ACC/AHA 2022 Class I — lifelong anti-impulse + BP control)
10. anticoagulation per indication warfarin or DOAC per indication PO per agent — Ongoing indication (AHA 2020 + ACC/AHA 2022)
11. statin per ASCVD risk atorvastatin 20-80 mg daily per LDL goal PO daily — ASCVD risk + dissection cohort secondary prevention (ACC/AHA 2018 cholesterol + 2022 aortic — comprehensive secondary prevention)
12. colchicine if late post-pericardiotomy syndrome 0.5 mg BID + ibuprofen 600 mg TID × 1-3 mo PO BID + TID — Symptomatic post-pericardiotomy syndrome (Imazio CIRCS NEJM 2015 PMID 26315582)

Non-pharmacologic actions:
- Cardiology follow-up q3-6 mo for first year then annually
- Cardiac surgery follow-up annually for first 3 yr then per stability
- Genetics follow-up if heritable disorder + family screening coordination
- Lifestyle: avoid isometric exercise, contact sports indefinitely; no straining/Valsalva; no smoking; BP self-monitoring
- Cardiac rehab maintenance phase
- Pregnancy counseling if female of childbearing age (high-risk multidisciplinary clinic)

AVOID / contraindication checks:
- Full_volume_pericardiocentesis_AVOID_in_dissection_precipitates_exsanguination (ACC/AHA 2022; Hayashi Circ J 2012)
- Isolated_vasodilator_without_BB_AVOID_reflex_tachycardia_propagates_dissection (ACC/AHA 2022 Class I)
- Positive_pressure_ventilation_AVOID_pre_drain_drops_preload_in_tamponade (ESC 2015 PMID 26320112; ACC/AHA 2022)
- Thrombolytics_ABSOLUTE_CONTRAINDICATION_in_aortic_dissection (ACC/AHA 2022)
- Aggressive_norepinephrine_AVOID_dissection_propagation_risk_titrate_to_lowest_perfusing_dose
- Nitroprusside_alone_AVOID_no_dP_dt_reduction_use_only_after_bb_control (ACC/AHA 2022)
- Esmolol_caution_severe_decompensated_hf_or_av_block (drug label)
- Nicardipine_avoid_severe_aortic_stenosis (drug label)

Monitoring

Regimen monitoring:
- continuous arterial line BP pre post drainage and OR (ACC/AHA 2022)
- continuous ECG (ACC/AHA 2022)
- transesophageal echo intraop for root repair adequacy (ACC/AHA 2022 Class I)
- serial hemoglobin q2h x 12h pre op then intraop per anesthesia
- paired BP arms documenting pulse differential (ACC/AHA 2022)
- serial neurologic exam q1h for malperfusion or postop stroke (ACC/AHA 2022)
- lower extremity motor exam for paraplegia spinal artery involvement (ACC/AHA 2022)
- serial lactate for organ malperfusion progression
- urine output hourly for renal malperfusion
- fluid analysis hematocrit post limited drainage compare to serum for active bleeding (ESC 2015)

Setting (outpatient) monitoring:
- Echo annually
- CT annually × 5 yr then per stability
- INR per anticoagulation
- Home BP + HR log

Monitoring phase: Intraop TEE for root repair adequacy + pericardial decompression; post-op CCU/ICU surveillance for re-bleeding, malperfusion, AKI, neurologic outcome, paraplegia (spinal artery), graft integrity (ACC/AHA 2022)

Disposition

Current setting: outpatient — Long-term surveillance for re-dissection, distal aortic progression, late graft complications, post-pericardiotomy late presentation, family screening completion (ACC/AHA 2022)

Disposition criteria:
- Long-term continuation under multidisciplinary team; cross-link to cardio.cardiac-tamponade.core.v1 for acute recurrence pathway if dissection recurs

Escalation triggers (move to higher acuity):
- Re-dissection (sudden tearing chest/back pain) → ED + emergent CT
- Distal aortic dilation/progression → cardiac surgery for repair planning
- Graft endocarditis (fever + bacteremia) → ID + cardiac surgery + IV antibiotics + possible explant
- New stroke or TIA → neurology + carotid evaluation + anticoagulation review
- Pregnancy in heritable disorder → maternal-fetal medicine + cardiology + cardiac surgery high-risk clinic

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [LIFE_THREATENING] Branch-vessel malperfusion (cerebral, coronary, mesenteric, renal, spinal, limb) accompanying Type A dissection-tamponade — multisystem organ ischemia (ACC/AHA 2022 PMID 36066317; Trimarchi IRAD)
- [LIFE_THREATENING] Lower extremity weakness/paralysis indicating Adamkiewicz artery (T8-L1) compromise during/after Type A repair — spinal cord ischemia (ACC/AHA 2022)
- [LIFE_THREATENING] New AKI (Cr doubled) or mesenteric ischemia (lactate >4 + abdominal pain + leukocytosis) following Type A repair — branch-vessel malperfusion sequelae (Trimarchi IRAD)

Citations

- 2022 ACC/AHA Aortic Disease Guideline (Isselbacher Circulation 2022 PMID 36066317) + 2014 ESC Aortic Disease Guideline (Erbel EHJ 2014 PMID 25173340) — remains current as of 2026-05-15. International Registry of Acute Aortic Dissection (IRAD; Hagan JAMA 2000 PMID 10685714 + Trimarchi updates) anchors mortality + outcome data; Hayashi Circ J 2012 + IRAD subgroup analyses anchor limited pericardiocentesis bridge controversy. ESC 2015 pericardial guideline (Adler EHJ 2015 PMID 26320112) cross-references for tamponade physiology baseline. [PMID:36066317](https://pubmed.ncbi.nlm.nih.gov/36066317/)
- Cited evidence (PMID 25173340) [PMID:25173340](https://pubmed.ncbi.nlm.nih.gov/25173340/)
- Cited evidence (PMID 10685714) [PMID:10685714](https://pubmed.ncbi.nlm.nih.gov/10685714/)
- Cited evidence (PMID 17307915) [PMID:17307915](https://pubmed.ncbi.nlm.nih.gov/17307915/)
- Cited evidence (PMID 26320112) [PMID:26320112](https://pubmed.ncbi.nlm.nih.gov/26320112/)

Last reconciled with current guidelines: 2026-05-15.
References
  • 2022 ACC/AHA Aortic Disease Guideline (Isselbacher Circulation 2022 PMID 36066317) + 2014 ESC Aortic Disease Guideline (Erbel EHJ 2014 PMID 25173340) — remains current as of 2026-05-15. International Registry of Acute Aortic Dissection (IRAD; Hagan JAMA 2000 PMID 10685714 + Trimarchi updates) anchors mortality + outcome data; Hayashi Circ J 2012 + IRAD subgroup analyses anchor limited pericardiocentesis bridge controversy. ESC 2015 pericardial guideline (Adler EHJ 2015 PMID 26320112) cross-references for tamponade physiology baseline. — PMID:36066317
  • Cited evidence (PMID 25173340) — PMID:25173340
  • Cited evidence (PMID 10685714) — PMID:10685714
  • Cited evidence (PMID 17307915) — PMID:17307915
  • Cited evidence (PMID 26320112) — PMID:26320112